498 - LONG-TERM IMPACT OF HIGH-NORMAL SYSTOLIC BLOOD PRESSURE ON THE RISK OF CARDIOVASCULAR DISEASE IN MEN. THE QUEBEC CARDIOVASCULAR STUDY
GR Dagenais, B Cantin, F Gagnon, B Lamarche, JP Despres
Quebec, Quebec

499 - CLINICAL OUTCOMES IN ALLHAT ANTIHYPERTENSIVE TRIAL PARTICIPANTS WITH TYPE 2 DIABETES, IMPAIRED FASTING GLUCOSE, AND NORMOGLYCEMIA
U Thadani, PK Whelton, J Barzilay, WC Cushman, BR Davis, E Llamathi, JB Kostis, FH Leenen, GT Louis, K Margolis, C Nwachuku, S Pressel
Oklahoma City, Oklahoma, USA

500 - NCEP AND WHO DEFINITIONS ARE EQUALLY PREDICTIVE OF METABOLIC SYNDROME IN SOUTH ASIAN BUT NOT IN EUROPEAN CANADIANS WITH CORONARY DISEASE: FINDINGS FROM THE PRACTICE REGISTRY
MK Gupta, M Tsigoulis
Brampton, Ontario

501 - THE METABOLIC SYNDROME LEADS TO WORSE LONG-TERM OUTCOMES AFTER PERCUTANEOUS CORONARY INTERVENTION
S De, JL Cox, LM Title, on behalf of the ICONS investigators
Halifax, Nova Scotia

502 - INFLUENCE OF METABOLIC SYNDROME ON THE OUTCOMES AFTER ACUTE CORONARY SYNDROMES AND MYOCARDIAL INFARCTION
S De, JL Cox, LM Title, on behalf of the ICONS investigators
Halifax, Nova Scotia

503 - ACHIEVE CHOLESTEROL TARGETS FAST WITH ATORVASTATIN STRATIFIED TITRATION: THE ACTFAST STUDY
A Langer, E de Teresa, C Farsang, A Gaw, GF Gensini, LA Leiter, P Martineau
Toronto, Ontario; Glasgow, United Kingdom; Florence, Italy